FDA Orange Book
Is there a generic for Lasix Onyu?
Lasix Onyu contains furosemide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Lasix Onyu (furosemide). The Orange Book shows its last listed patent expires January 10, 2042.
Run it in Rivvi
Map Lasix Onyu and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Lasix Onyu products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, subcutaneous | 80MG/2.67ML (30MG/ML) | Marketed (Rx) | None | 0 | None |
NDA 217294, held by SQ INNOVATION INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Lasix Onyu patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11246851 | January 3, 2040 | Drug product | U-4576 | 217294 |
| 12318363 | January 3, 2040 | Drug product | None | 217294 |
| 12403120 | January 10, 2042 | Drug product | U-4576 | 217294 |
Lasix Onyu NDC codes
Questions
Is there a generic for Lasix Onyu?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Lasix Onyu (furosemide). The Orange Book shows its last listed patent expires January 10, 2042.
What is the generic name for Lasix Onyu?
The active ingredient in Lasix Onyu is furosemide, per the FDA Orange Book.
When does the Lasix Onyu patent expire?
The last patent listed for Lasix Onyu in the Orange Book expires January 10, 2042. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.